Understanding Different Validation Types in the Pharmaceutical Sector

Validation in the pharmaceutical industry is a critical aspect that ensures processes, methods, systems, facilities, and equipment perform reliably and consistently. The approach to validation can differ based on the lifecycle stage of the product, the specifics of the process, and the regulatory framework in place. It's essential for professionals in the field to understand the various validation types to avoid employing inappropriate methods that might compromise validation outcomes.

1. Prospective Validation: Establishing Evidence Prior to Production

Prospective validation takes place before the commencement of routine commercial production. This validation requires pre-approved protocols and established acceptance criteria. It typically involves executing validation batches that have been pre-planned. This approach is particularly important when introducing new products, significant process modifications, or new equipment configurations. A typical prospective validation exercise involves:

• Identifying critical quality attributes (CQAs) and critical process parameters (CPPs)
• Conducting risk assessments
• Qualifying equipment and utilities
• Approving manufacturing processes
• Defining sampling and testing protocols
• Implementing validation batches

It is crucial for the protocol to outline the necessary evidence even before results are available. According to FDA guidelines, the process qualification stage assesses whether process designs can yield commercially reproducible outcomes.

2. Concurrent Validation: Data Collection During Active Manufacturing

Concurrent validation involves gathering and analysing validation data while the actual manufacturing process is ongoing. This method was historically applied in situations where prospective validation was not feasible or where validation during production was justified. However, it necessitates robust protocols, adequate controls, and appropriate equipment. It is imperative for QA professionals to scrutinise the justification for choosing concurrent validation over prospective validation to ensure it's appropriately warranted.

3. Retrospective Validation: Leveraging Historical Data

Retrospective validation uses historical manufacturing and quality data to confirm that a process has adhered to its design specifications. Unlike prospective validation, the evidence here is pre-existing and relevant to the verification process. Historical data may encompass:

• Manufacturing and testing records
• Process parameter results
• Final product outcomes
• Incident reports
• Out-of-specification (OOS) and Out-of-trend (OOT) analyses
• Trends in process performance
• Maintenance records

Retrospective validation should not merely be a review of successful batches; according to WHO guidelines, it should only be applied in exceptional circumstances, where sufficient historical data is available. The FDA’s Q7A guidance recommends this validation type under strict conditions, particularly for well-established active pharmaceutical ingredients (APIs).

4. Revalidation: Validating Continued Compliance

Revalidation is necessary to reaffirm the validity of existing validations when there are changes, new evidence, or other factors that could impact the validated status. Triggers for revalidation may include:

• Significant equipment modifications
• Changes in manufacturing processes
• Adjustments in raw material composition
• Facility or utility system reorganisations
• Alterations in critical process parameters
• Frequent deviations or complaints related to the process

It's important to note that revalidation does not necessarily require a full re-execution of the original validation; the extent needed will depend on the nature of the change and potential impacts on product quality.

5. Validation Strategies in the Lifecycle Paradigm

The modern approach to validation shifts from viewing it as a one-time activity to a lifecycle process. The FDA outlines three stages that comprise this validation lifecycle:

Overview: stage 1: Process Design

This stage involves establishing the final commercial manufacturing process based on insights gained during process development and scale-up.

Overview: stage 2: Process Qualification

In this stage, various facets of manufacturing—including facility design, equipment, utilities, and the process itself—are tested to verify their capability for consistent execution.

Overview: stage 3: Continued Process Verification

This stage focuses on the ongoing testing and monitoring of data collected during manufacturing to ensure processes remain under control. It's crucial for companies to understand that initial validation does not imply everlasting validation.

6. Validation Types Based on the Subject Matter

Validation actions vary depending on what is being validated. Common types include:

• Process validation: Confirms that production processes consistently yield products meeting quality specifications.
• Cleaning validation: Ensures that cleaning methods achieve required cleanliness levels.
• Analytical method validation: Verifies that analytical techniques are suitable for their intended purposes.
• Computer system validation: Confirms that computerized systems function as required by regulations.
• Sterilization validation: Establishes the efficacy and consistency of sterilisation processes.
• Equipment and utility qualification: Validates that equipment is appropriate for its intended use.

While these validation types are interconnected, they should not be conflated; for instance, process validation cannot be substituted by equipment qualification.

7. Determining the Appropriate Validation Approach

When considering a validation strategy, it’s essential to assess the lifecycle stage of the product, understanding the involved processes, associated risks, and regulatory commitments. QA professionals need to address the following inquiries:

• What specifically is being validated?
• What is the process's intended purpose?
• What prior knowledge exists?
• What known risks are associated?
• How was the chosen method determined?
• Are the relevant systems adequately qualified?
• Are acceptance criteria clearly defined?
• What effects might deviations have?
• What monitoring practices will ensure process stability?

During a review process, inspectors will likely expect justifications for selected validation methods, supported by the validation master plan and strategy.

8. A Holistic Perspective on Validation

While traditional definitions of validation remain valid, it's essential for pharmaceutical companies to view them in a more integrated manner. Prospective validation focuses on acquiring evidence before production begins, while ongoing validation utilises real-time manufacturing activities for evidence gathering. Retrospective validation evaluates historical data, and revalidation occurs when changes or new evidence necessitate a reassessment. Embracing a lifecycle model connects these activities with the accumulated knowledge regarding process development, qualification, and performance. Ultimately, the goal transcends mere validation; it involves maintaining documented evidence that confirms processes, systems, methods, or equipment continue to meet necessary standards throughout their lifecycle.